1796565-52-0

MDK-5220 exhibits an orexin agonist activity and is expected to be useful as an excellent therapeutic or preventive agent for narcolepsy Orexin 2 Receptor Agonist is a potent (EC50 on OX2R is 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio is 70) agonist.